# Tim Keane

> Tim Keane is the Houston-based co-founder and CEO of TYBR Health. He earned engineering degrees at the University of Pittsburgh, conducted postdoctoral research at Imperial College London and joined the Texas Medical Center Biodesign fellowship in 2019. TYBR was founded in 2020, joined Y Combinator’s Winter 2022 batch and announced a $30 million Series A financing in July 2026.

- **Role:** Co-founder and CEO at TYBR Health
- **Organizations:** TYBR Health, University of Pittsburgh, Imperial College London, Texas Medical Center, Y Combinator, MedTech Innovator
- **Education:** BSc, Chemical Engineering; minor in Bioengineering, University of Pittsburgh, PhD, Bioengineering, University of Pittsburgh, Postdoctoral research fellowship (not a degree), Imperial College London, Biodesign fellowship (not a degree), Texas Medical Center
- **Known for:** National Science Foundation Graduate Research Fellowship, 2013., University of Pittsburgh Research Assistant of the Year, 2014., University of Pittsburgh Bridgeside Research Forum Best Talk Award, 2016.

## Career timeline

- **2009** — Engineering intern at MSA - The Safety Company.
- **2010** — Began student research at the McGowan Institute.
- **2011** — Completed his chemical engineering BSc at the University of Pittsburgh.
- **2012-2016** — Graduate research at the University of Pittsburgh; NSF Graduate Research Fellow from 2013.
- **2016-2019** — Postdoctoral fellow at Imperial College London in Molly Stevens’s laboratory.
- **2019** — Joined the Texas Medical Center Biodesign program in August; worked with Alex Smith and Stephen Ramon.
- **2020** — TYBR Health founded; Keane became co-founder and CEO.
- **2022** — TYBR participated in Y Combinator’s Winter 2022 batch.
- **2024** — TYBR participated in the MedTech Innovator cohort.
- **2026** — TYBR announced a $30 million Series A financing on July 21.

## Achievements

- National Science Foundation Graduate Research Fellowship, 2013.
- University of Pittsburgh Research Assistant of the Year, 2014.
- University of Pittsburgh Bridgeside Research Forum Best Talk Award, 2016.
- Whitaker International Scholar, 2016.
- Horizon 2020 Marie Skłodowska-Curie Individual Fellow, 2017.
- Co-founded TYBR Health, a Y Combinator Winter 2022 company.

## Latest updates

- **2026-07** — TYBR announced a $30 million Series A financing led by Vensana Capital and Mutual Capital Partners, with participation from Neovate Capital Partners and existing investors. The announcement named Greg Banker, Liz Todia Zambory and Aaron Smith as joining the board.
- **2026-08** — MedTech Innovator listed Keane as a panelist for its August 6 session on structuring financing rounds.
- **2026-10** — The Musculoskeletal New Ventures Conference lists Keane as TYBR’s co-founder and CEO for its October 27-28, 2026 event in Memphis; the event is upcoming as of October 25.

## Links

- Website: https://www.tybrhealth.com/
- LinkedIn: https://www.linkedin.com/in/timjkeanejr

---

Profile page: https://yespress.io/tim-keane
Published by YesPress — https://yespress.io
Last updated: 2026-10-25